Stability and Activity of Interferon Beta to Treat Idiopathic Pulmonary Fibrosis with Different Nebulizer Technologies-Reference-Cited by-同舟云学术

Stability and Activity of Interferon Beta to Treat Idiopathic Pulmonary Fibrosis with Different Nebulizer Technologies

Published:2023-04-01 Issue:2 Volume:36 Page:55-64
ISSN:1941-2711
Container-title:Journal of Aerosol Medicine and Pulmonary Drug Delivery
language:en
Short-container-title:Journal of Aerosol Medicine and Pulmonary Drug Delivery

Author:

Brun Edgar Hernan Cuevas¹,Hong Zuo-Yi²,Hsu Yuan-Ming¹,Wang Ciou-Ting¹,Chung Dai-Jung²,Ng Shang-Kok²,Lee Yau-Hsuan²,Wei Tzu-Tang²³^ORCID

Affiliation:

1. HCmed Innovations Co., Ltd., Taipei, Taiwan.

2. Department and Graduate Institute of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan.

3. Chemical Biology and Molecular Biophysics, Taiwan International Graduate Program in Chemical Biology and Molecular Biophysics (TIGP-CBMB), Academia Sinica, Taipei, Taiwan.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmaceutical Science,Pulmonary and Respiratory Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/jamp.2022.0020

Reference44 articles.

1. Idiopathic pulmonary fibrosis

2. Idiopathic pulmonary fibrosis

3. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

4. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A dry powder formulation for peripheral lung delivery and absorption of an anti-SARS-CoV-2 ACE2 decoy polypeptide;European Journal of Pharmaceutical Sciences;2023-12